2.66

4.31% 0.11

Creative Medical Technology Holdings Inc (CELZ)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$2.55

Aprire:

$2.51

Volume 24 ore:

18,553

Relative Volume:

0.52

Capitalizzazione di mercato:

$4.35M

Reddito:

$102.80K

Utile/perdita netta:

$-5.28M

Rapporto P/E:

-0.3556

EPS:

-7.48

Flusso di cassa netto:

$-5.08M

1 W Prestazione:

+0.00%

1M Prestazione:

-41.79%

6M Prestazione:

-39.55%

1 anno Prestazione:

-37.56%

Intervallo 1D:

$2.44

$2.67

Intervallo di 1 settimana:

$2.4101

$2.83

Portata 52W:

$2.4101

$10.28

Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile

Nome

Creative Medical Technology Holdings Inc

Settore

Healthcare (1195)

Industria

Biotechnology (683)

Telefono

480-399-2822

Indirizzo

211 E. OSBORN RD., PHOENIX

Dipendente

Cinguettio

Prossima data di guadagno

2024-11-12

Ultimi documenti SEC

CELZ's Discussions on Twitter

Confronta CELZ con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CELZ	2.63	4.35M	102.80K	-5.28M	-5.08M	-7.48
VRTX	449.11	115.43B	10.63B	-479.80M	-1.35B	13.33
REGN	746.63	82.04B	13.85B	4.65B	3.32B	35.06
ARGX	597.08	35.30B	1.86B	-40.29M	-1.28B	-4.16
ALNY	246.44	32.04B	2.09B	-332.26M	16.06M	-4.14
BNTX	108.09	24.89B	3.30B	-501.07M	1.03B	11.54

Creative Medical Technology Holdings Inc Borsa (CELZ) Ultime notizie

Nov 18, 2024

CELZ stock touches 52-week low at $2.49 amid market challenges By Investing.com - Investing.com South Africa

Nov 18, 2024

Can Creative Global Technology Holdings Limited's (NASDAQ:CGTL) ROE Continue To Surpass The Industry Average? - Yahoo Finance

Nov 18, 2024

Equities Analysts Issue Forecasts for CELZ FY2024 Earnings - Defense World

Nov 18, 2024

Novozymes A/S (OTCMKTS:NVZMY) & Creative Medical Technology (NASDAQ:CELZ) Head-To-Head Comparison - Defense World

Nov 18, 2024

CELZ stock touches 52-week low at $2.49 amid market challenges - Investing.com Canada

Nov 18, 2024

Nov 17, 2024

Q1 Earnings Estimate for CELZ Issued By Roth Capital - Defense World

Nov 17, 2024

Nov 15, 2024

Creative Medical Technology files to sell 0.83M shares of common stocks by selling shareholders - MSN

Nov 15, 2024

Nov 14, 2024

Creative Technology (SGX:C76) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Nov 14, 2024

Mesa medical manufacturer BioLab Holdings Inc. hires new COO - Daily Independent

Nov 14, 2024

Nov 13, 2024

Creative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial with Positive Independent - EIN News

Nov 13, 2024

Creative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial with Positive Independent Review, Validating the Safety and Potential of CELZ-201 for Chronic Lower Back Pain Treatment - The Manila Times

Nov 13, 2024

Electrify Expo Expands to New Markets in 2025 as Dallas and Chicago Join the Nation's Largest EV Festival - The Manila Times

Nov 13, 2024

Creative Medical passes safety review for back pain trial By Investing.com - Investing.com UK

Nov 13, 2024

Creative Medical Tech's CELZ-201 Back Pain Trial Advances After Positive Safety Review | CELZ Stock News - StockTitan

Nov 13, 2024

Creative Planning Lowers Holdings in Mirion Technologies, Inc. (NYSE:MIR) - Defense World

Nov 13, 2024

Nov 11, 2024

Creative Planning Buys New Stake in GigaCloud Technology Inc. (NASDAQ:GCT) - Defense World

Nov 11, 2024

Nov 10, 2024

Creative Medical Technology Holdings Third Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.02 loss in 3Q 2023) - Yahoo Finance UK

Nov 10, 2024

Creative Planning Purchases 22,171 Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) - Defense World

Nov 10, 2024

Nov 09, 2024

Creative Planning Has $334,000 Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World

Nov 09, 2024

Creative Medical Technology Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 09, 2024

Nov 08, 2024